Skip to main content
. 2015 Aug 4;5(2):152–160. doi: 10.1093/jpids/piv039

Figure 2.

Figure 2.

Percentage of subjects with hSBA titers ≥1:8 against N meningitidis serogroup B test strains A22, A56, B24, and B44 at baseline and 1 month after injection with bivalent rLP2086 or saline. Errors shown are 95% confidence intervals. hSBA, human serum bactericidal antibody assay using human complement.